Subscribe to Newsletter

Business Practice

Manufacture Technology and Equipment

Feeling the Heat

| Nico Ros | 3 min read

Transporting temperature-sensitive pharmaceuticals is only going to become more challenging as we face the realities of the climate crisis.

Business & Regulation Digital Technologies

Preparing for the Worst Case

| Dave Edwards | 8 min read

How to ensure your reaction to recalls is driven by data and knowledge.

Manufacture Process Control

Redefining Manufacturing

| Rob Coker

Watch our roundtable discussion featuring experts from Terumo Blood and Cell Technologies, Orgenesis, ScaleReady, and BioBridge Global

Business & Regulation Business Practice

Enter the Humira Biosimilars

| Stephanie Vine | 2 min read

Humira biosimilars finally launch on the US market

Business & Regulation Business Practice

Drug Pricing Lawsuits Ramp Up

| Stephanie Vine | 5 min read

More pharma stakeholders are launching lawsuits over the US government’s Inflation Reduction Act.

Discovery & Development Drug Delivery

Revenge of the ADCs

| Stephanie Vine | 15 min read

Are antibody drug conjugates (ADCs) the breakthrough in cancer treatment? Experts share insights on recent advancements

Manufacture Bioprocessing - Upstream & Downstream

Creating for Tomorrow

| Sponsored by Asahi Kasei | 7 min read

We interview Clayton Weber, Systems Engineering Lead/ Sustainability Lead at Asahi Kasei Bioprocess

Business & Regulation Business Practice

Never Break the Chain

| Nadine Lampka | 5 min read

How do we prevent criminals from reusing primary packaging for counterfeit medicines? Labeling solutions and other creative concepts can help.

Manufacture Contract Manufacturing Services

Six of the Best

| 2 min read

Germany-based CDMO Vetter received six nominations in the 2023 CDMO Leadership Awards. Here, Carsten Press shares his thoughts on the achievement.

Business & Regulation Standards & Regulation

MSD Files Lawsuit Against US Government

| Stephanie Vine | 4 min read

MSD describes drug price negotiation program as “sham” and “tantamount to extortion”

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register